胰岛素刺激的GLUT4内体贩运 - 模型的改变?
Makoto Kanzaki1, Gwyn W Gould2
1Department of Biomedical Engineering, Graduate School of Biomedical Engineering, Tohoku University, Sendai, 980-8579, Japan.
Journal of cell science
|December 22, 2025
概括
胰岛素触发GLUT4 (也称为SLC2A4) 囊泡与内分泌体融合,这一过程称为融合引导GLUT4入口 (FGG4E). 这使得GLUT4能够动态移动,改善葡萄糖吸收和胰岛素敏感性.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 生理学 生理学 生理学
背景情况:
- 胰岛素反应性葡萄糖输送体4型 (GLUT4) 贩运对于葡萄糖恒温至关重要.
- 之前的模型专注于GLUT4囊泡动员,但早期的贩运步骤仍然不清楚.
研究的目的:
- 阐明胰岛素诱导的GLUT4贩运的初始分子机制.
- 建议对GLUT4贩运进行修订,并纳入新发现的模型.
主要方法:
- 空间时间分辨率成像成像
- 单个分子标签的标签.
- 使用量子点跟踪的活细胞试验.
- 基于光的聚变报告器.
主要成果:
- 确定了静态GLUT4囊泡和转移素受体阳性内分泌体之间的胰岛素诱导的异型融合.
- 定义了"融合引导GLUT4入口" (FGG4E) 作为GLUT4调动的分子门户.
- 证明FGG4E能够使GLUT4在内体网络和血膜内的动态循环.
结论:
- 异型囊泡融合作为一个关键的门户,调节GLUT4的调动和循环.
- 修订后的模型重新定义了GLUT4贩运,超出了经典的囊泡动员.
- 这一途径是有效吸收葡萄糖和胰岛素敏感性的关键.
相关概念视频
Insulin Secretory Vesicles
6.3K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.3K
Insulin: The Receptor and Signaling Pathways
2.6K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.6K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.1K
Hormones Regulating Blood Glucose
6.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.3K
The Early Endosome: Endocytosis of Transferrin
4.6K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
4.6K
Glucagon-like Receptor Agonists
818
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
818


